Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy. [electronic resource]
Producer: 20150102Description: 464-70 p. digitalISSN:- 1445-5994
- Adalimumab
- Adrenal Cortex Hormones -- pharmacology
- Adult
- Anti-Inflammatory Agents -- adverse effects
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Colectomy -- statistics & numerical data
- Colitis, Ulcerative -- drug therapy
- Disease-Free Survival
- Drug Resistance
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Immunosuppressive Agents -- administration & dosage
- Infliximab
- Male
- Mesalamine -- administration & dosage
- Middle Aged
- Observational Studies as Topic
- Prognosis
- Proportional Hazards Models
- Randomized Controlled Trials as Topic
- Recurrence
- Remission Induction
- Risk Factors
- Severity of Illness Index
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.